Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

Neighbors organized a car wash fundraiser to support 9-year-old Logan Coyle, a local boy who has faced unimaginable medical ...

“By uncovering specific genetic vulnerabilities like the CDS1 and CDS2 relationship, we’re opening the door to new therapies ...

Background Diagnosing the presence of metastasis of pancreatic cancer is pivotal for patient management and treatment, with ...

The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy, to be ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...

Application error: a client-side exception has occurred (see the browser console for more information).

"Rising liver disease cases and biotech innovations are fueling demand for advanced therapies, with personalized medicine and fibrosis-targeting treatments shaping the global market landscape." BOSTON ...

This study published in Engineering offers new insights into the impact of alcoholic liver disease (ALD) on post-transplant ...